Lampertico P - Search Results

1

Bulevirtide with or without pegIFNα for patients with compensated chronic hepatitis delta: From clinical trials to real-world studies.

Lampertico P, Roulot D, Wedemeyer H. Lampertico P, et al. J Hepatol. 2022 Nov;77(5):1422-1430. doi: 10.1016/j.jhep.2022.06.010. Epub 2022 Jun 22. J Hepatol. 2022. PMID: 35752223 Review.

2

Long-term suppression of hepatitis B e antigen-negative chronic hepatitis B by 24-month interferon therapy.

Lampertico P, Del Ninno E, Viganò M, Romeo R, Donato MF, Sablon E, Morabito A, Colombo M. Lampertico P, et al. Hepatology. 2003 Apr;37(4):756-63. doi: 10.1053/jhep.2003.50148. Hepatology. 2003. PMID: 12668967 Clinical Trial.

3

Long-term lamivudine monotherapy in renal-transplant recipients with hepatitis-B-related cirrhosis.

Viganò M, Colombo M, Aroldi A, Lunghi G, Manenti E, Ponticelli C, Lampertico P. Viganò M, et al. Among authors: lampertico p. Antivir Ther. 2005;10(6):709-13. Antivir Ther. 2005. PMID: 16218169 Clinical Trial.

4

Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine.

Lampertico P, Viganò M, Manenti E, Iavarone M, Lunghi G, Colombo M. Lampertico P, et al. Hepatology. 2005 Dec;42(6):1414-9. doi: 10.1002/hep.20939. Hepatology. 2005. PMID: 16317671

5

Entecavir versus lamivudine for HBeAg positive and negative chronic hepatitis B.

Lampertico P. Lampertico P. J Hepatol. 2006 Sep;45(3):457-60. doi: 10.1016/j.jhep.2006.06.012. Epub 2006 Jul 10. J Hepatol. 2006. PMID: 16844254 No abstract available.

6

HBeAg-negative chronic hepatitis B: why do I treat my patients with nucleos(t)ide analogues.

Lampertico P, Colombo M. Lampertico P, et al. Liver Int. 2009 Jan;29 Suppl 1:130-2. doi: 10.1111/j.1478-3231.2008.01931.x. Liver Int. 2009. PMID: 19207976 Review.

7

The course of inactive hepatitis B in hepatitis-C-coinfected patients treated with interferon and ribavirin.

Viganò M, Aghemo A, Iavarone M, Rumi MG, Agnelli F, Lampertico P, Donato MF, Colombo M. Viganò M, et al. Among authors: lampertico p. Antivir Ther. 2009;14(6):789-96. doi: 10.3851/IMP1284. Antivir Ther. 2009. PMID: 19812441

8

Transient elastography assessment of the liver stiffness dynamics during acute hepatitis B.

Viganò M, Massironi S, Lampertico P, Iavarone M, Paggi S, Pozzi R, Conte D, Colombo M. Viganò M, et al. Among authors: lampertico p. Eur J Gastroenterol Hepatol. 2010 Feb;22(2):180-4. doi: 10.1097/MEG.0b013e328332d2fa. Eur J Gastroenterol Hepatol. 2010. PMID: 19855283

9

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Papatheodoridis GV, et al. Among authors: lampertico p. J Hepatol. 2010 Aug;53(2):348-56. doi: 10.1016/j.jhep.2010.02.035. Epub 2010 Apr 27. J Hepatol. 2010. PMID: 20483498 Free article. Review.

10

Etiology-related determinants of liver stiffness values in chronic viral hepatitis B or C.

Fraquelli M, Rigamonti C, Casazza G, Donato MF, Ronchi G, Conte D, Rumi M, Lampertico P, Colombo M. Fraquelli M, et al. Among authors: lampertico p. J Hepatol. 2011 Apr;54(4):621-8. doi: 10.1016/j.jhep.2010.07.017. Epub 2010 Oct 1. J Hepatol. 2011. PMID: 21146243 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

383 results

Search Page